Rowe Jeffrey M 4
4 · Zomedica Corp. · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Rowe Jeffrey M
Director
Transactions
- Purchase
Common Stock, without par value
2025-03-17$0.06/sh+500,000$32,000→ 775,000 total(indirect: By Trust) - Purchase
Common Stock, without par value
2025-03-17$0.07/sh+731,368$49,733→ 1,675,015 total(indirect: By Trust) - Purchase
Common Stock, without par value
2025-03-17$0.07/sh+34,725$2,465→ 1,714,005 total(indirect: By Trust) - Purchase
Common Stock, without par value
2025-03-17$0.07/sh+100,647$7,045→ 875,647 total(indirect: By Trust) - Purchase
Common Stock, without par value
2025-03-17$0.07/sh+68,000$4,556→ 943,647 total(indirect: By Trust) - Purchase
Common Stock, without par value
2025-03-17$0.07/sh+4,265$299→ 1,679,280 total(indirect: By Trust)
Holdings
- 11,965,480(indirect: See Footnote)
Common Stock, without par value
Footnotes (1)
- [F1]664,480 shares held by M. Rowe Living Trust, 11,120,000 held by Rowe Family GST and 181,000 held by IRA.